Table 2 Summary of the Subgroup Analysis of the Prevalence of Sarcopenia in T2DM Patients
Subgroup Category | Subgroup | Number of Studies (k) | Heterogeneity I2 (%) | Effect Model | Prevalence % [95% CI] |
|---|---|---|---|---|---|
Geographic Region | Western Pacific | 34 | 95.0 | Random | 21.95 [18.13–26.19] |
|  | South‒East Asia | 5 | 94.0 | Random | 37.46 [22.51–55.17] |
Study Setting | Hospital-based | 32 | 94.0 | Random | 22.31 [18.45–26.69] |
|  | Community-based | 7 | 97.0 | Random | 33.64 [20.85–49.24] |
Measurement Tool | BIA | 19 | 93.0 | Random | 19.52 [14.87–25.16] |
|  | DXA | 20 | 96.0 | Random | 29.86 [23.77–36.77] |
Study Period | Pre- 2022 | 12 | 96.0 | Random | 18.42 [12.43–26.42] |
|  | 2023–2024 | 27 | 95.0 | Random | 27.85 [23.09–33.16] |
Sample Size |  < 200 | 7 | 90.0 | Random | 38.54 [26.95–51.57] |
|  | 200–500 | 19 | 93.0 | Random | 25.95 [20.67–32.04] |
|  |  > 500 | 13 | 97.0 | Random | 17.40 [12.39–23.85] |
Age Groups |  < 60 years | 4 | 94.0 | Random | 35.48 [21.95–51.67] |
|  | 60–70 years | 24 | 95.0 | Random | 22.47 [17.91–27.77] |
|  |  > 70 years | 11 | 94.0 | Random | 24.82 [17.73–33.55] |
Gender | Male | 29 | 95.0 | Random | 25.98 [21.05–31.60] |
|  | Female | 29 | 94.0 | Random | 22.84 [18.31–28.12] |